Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors

Shenghua GAO; Tianguang HUANG; Letian SONG; Shujing XU; Yusen CHENG; Srinivasulu CHERUKUPALLI; Dongwei KANG; Tong ZHAO; Lin SUN; Jian ZHANG; Peng ZHAN; Xinyong LIU.
Acta Pharmaceutica Sinica B ; (6): 581-599, 2022.
Artículo en Inglés | WPRIM | ID: wpr-929274

Documentos relacionados

  1. Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19.
  2. [Series: Caries prevention in a historical perspective. Food].
  3. The Life of SARS-CoV-2 Inside Cells: Replication-Transcription Complex Assembly and Function.
  4. Identification of herbal teas and their compounds eliciting antiviral activity against SARS-CoV-2 in vitro.
  5. Analysis of the N-glycosylation profiles of the spike proteins from the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2.
  6. Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2-Induced Inflammation.
  7. Machine learning enabled identification of potential SARS-CoV-2 3CLpro inhibitors based on fixed molecular fingerprints and Graph-CNN neural representations.
  8. MSC-derived exosomes carrying a cocktail of exogenous interfering RNAs an unprecedented therapy in era of COVID-19 outbreak.
  9. Modulation of various host cellular machinery during COVID-19 infection.
  10. Development of COVID-19 therapies: Nonclinical testing considerations.